IQSM is an exchange-traded fund — it holds a basket of underlying assets rather than being a single operating company.
Company fundamentals like P/E, revenue, EPS and profit margins don't apply to a fund — its value comes from the assets it holds, not its own earnings. Use the price chart, options and model forecast below for fund-level analysis.
An institutional-grade, numbers-driven thesis on IQSM — generated on demand from live fundamentals, scores and forecast.
Member feature · 7-day free trial · no charge today · cancel anytime
As of July 4, 2026, TradersQuant's model rates NYLI Candriam U.S. Mid Cap Equity ETF (IQSM) 53/100 with a 12-month base-case forecast of $45.24 — +14.6% versus the current price of $39.46. NYLI Candriam U.S. Mid Cap Equity ETF trades at $39.46 in the Financial Services sector, with a market capitalisation of $249.7M. The score blends valuation, growth, earnings quality and momentum into a single grade.
The 12-month TradersQuant model price target for IQSM is $45.24, implying +14.6% versus the current price. The model's 12-month scenario range runs from $38.98 (bear) to $54.16 (bull), with a base case of $45.24.
IQSM currently carries a TradersQuant composite score of 53/100, which we read as a neutral-to-watch signal. Our 12-month price target of $45.24 implies +14.6% from $39.46. This is research, not financial advice — always combine it with your own judgement.
The TradersQuant 12-month model price target for IQSM is $45.24, about +14.6% versus the latest price of $39.46.
TradersQuant's 12-month model forecast for IQSM is a base case of $45.24, ranging from $38.98 (bear) to $54.16 (bull), an expected return of +14.7%. Forecasts are model estimates, not guarantees.
The TradersQuant price prediction for IQSM over the next 12 months is $45.24 in the base case (bear $38.98, bull $54.16), versus today's price of $39.46. Unlike black-box prediction sites, every TradersQuant call is logged at the price and date it was made and graded publicly against the S&P 500.
We deliberately don't publish 2030 price predictions for IQSM — no model can honestly forecast a single stock five-plus years out, and sites that do are guessing. TradersQuant focuses on a rigorous 12-month bull/base/bear range, refreshed continuously and graded on our public track record.
TradersQuant estimates IQSM's fair value at $49.96, implying +26.6% of expected upside versus the current price.
NYLI Candriam U.S. Mid Cap Equity ETF does not currently pay a dividend.
Data and model outputs are for research only and are not financial advice. Figures update continuously.
